Francesca Barone

CIK: 0001909680

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (55.6%)

Position reduction

Option Exercises (M)1 (11.1%)

Derivative conversions

Awards (A)3 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CADL

Candel Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

CADL
Candel Therapeutics, Inc.
Jun 29, 2026
Sale(S)
Direct
23.4K shares at avg. $10.06$236K
CADL
Candel Therapeutics, Inc.
Jan 26, 2026
Award(A)
Stock Option (Right to Buy)
Direct
232K shares-
CADL
Candel Therapeutics, Inc.
Jun 25, 2025
Award(A)
Direct
4.3K shares at avg. $4.67$20K
CADL
Candel Therapeutics, Inc.
Mar 18, 2025
Sale(S)
Direct
32.1K shares at avg. $8.76$282K
CADL
Candel Therapeutics, Inc.
Mar 18, 2025
Exercise(M)
Direct
18K shares at avg. $1.55$28K
CADL
Candel Therapeutics, Inc.
Feb 12, 2025
Award(A)
Stock Option (Right to Buy)
Direct
115K shares-
CADL
Candel Therapeutics, Inc.
Jan 15, 2025
Sale(S)
Direct
13.5K shares at avg. $7.22$98K
CADL
Candel Therapeutics, Inc.
Jan 8, 2025
Sale(S)
Direct
13.7K shares at avg. $8.22$112K
CADL
Candel Therapeutics, Inc.
Nov 29, 2024
Sale(S)
Direct
22.1K shares at avg. $4.56$101K

		Type	Shares	Price		Ownership
Jun 29, 2026	CADL Candel Therapeutics, Inc.	Sale(S)	23,447	$10.06	$235,769	Direct
Jan 26, 2026	CADL Candel Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	232,000	-	-	Direct
Jun 25, 2025	CADL Candel Therapeutics, Inc.	Award(A)	4,282	$4.67	$19,997	Direct
Mar 18, 2025	CADL Candel Therapeutics, Inc.	Sale(S)	32,146	$8.76	$281,673	Direct
Mar 18, 2025	CADL Candel Therapeutics, Inc.	Exercise(M)	18,000	$1.55	$27,900	Direct
Feb 12, 2025	CADL Candel Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	115,000	-	-	Direct
Jan 15, 2025	CADL Candel Therapeutics, Inc.	Sale(S)	13,534	$7.22	$97,783	Direct
Jan 8, 2025	CADL Candel Therapeutics, Inc.	Sale(S)	13,673	$8.22	$112,367	Direct
Nov 29, 2024	CADL Candel Therapeutics, Inc.	Sale(S)	22,081	$4.56	$100,592	Direct

1-9 of 9 transactions

About Barone Francesca

Barone Francesca (SEC CIK 0001909680) files insider reports with the SEC as Chief Scientific Officer of Candel Therapeutics, Inc. (CADL).

Signal8 holds 8 ownership filings by Barone Francesca, all Form 4s, filed between Dec 3, 2024 and Jul 1, 2026. Those filings report 9 transactions, from Nov 29, 2024 to Jun 29, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Barone Francesca's filings is in NEEDHAM, MA.

Recent filings by Barone Francesca

Jun 29, 2026: Open-market sale of CADL shares (Form 4, code S).
Jan 26, 2026: Grant or award of CADL derivative securities (Form 4, code A).
Jun 25, 2025: Grant or award of CADL shares (Form 4, code A).
Mar 18, 2025: Open-market sale of CADL shares (Form 4, code S).
Mar 18, 2025: Option exercise of CADL shares (Form 4, code M).

Other insiders filing for Candel Therapeutics, Inc. (CADL)

Loggia Nicoletta, Director
PAPA JOSEPH C, Director
Manning Paul B, Director
Tak Paul Peter, Chief Executive Officer
Zimmermann Martine, Director
Tyagarajan Seshu, Chief Technology Officer

How to read Form 4 transaction codes